Jamaica: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)

Jamaica continues to be an important market for U.S. bulk, intermediate, and high value agricultural products, with a total value of approximately $394 million in 2018. In Jamaica, there is currently no commercial production of genetically engineered (GE) crops. In addition, Jamaica does not have a biotechnology or biosafety legal framework for the deregulation or commercialization of biotechnology crops and does not have specific requirements for GE imports. There are current regulations that govern the importation of GE products for experimental purposes, such as field testing for cultivation. In addition, Jamaica’s draft biotechnology policy, which has been in draft form for several years, explicitly states the need for mandatory labeling of GE products.  

Jamaica: Agricultural Biotechnology Annual

Related Reports

The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Attaché Report (GAIN)

Tunisia: Agricultural Biotechnology Annual

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.
Attaché Report (GAIN)

Thailand: Rice Price - Weekly

Export prices of white and parboiled rice rose one percent from the previous week as exporters reportedly continued to secure the rice supplies to fulfill contract shipments.